Trans-​2-​Hexenal

CAT: 0804-HY-128429-01Size: 5 gDry Ice: NoHazardous: No
CAT#:0804-HY-128429-01Size:5 g
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Trans-2-Hexenal ((E) -2-Hexenal) is a volatile compound widely present in fresh plants, vegetables, and fruits, with a unique leafy aroma. trans-2-Hexenal has antifungal activity and can also inhibit the germination of soybean seeds and the growth of seedlings. In addition, trans-2-Hexenal can be used to determine low-molecular-weight carbonyl compounds that are reactive with biological nucleophiles in biological samples[1][2][3][4].
CAS Number
[6728-26-3]
Product Name Alternative
(E) -2-Hexenal
UNSPSC
12352211
Hazard Statement
H226, H302, H311
Target
Biochemical Assay Reagents; Fungal
Type
Natural Products
Related Pathways
Anti-infection; Others
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/trans-2-hexenal.html
Purity
99.59
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CCC/C=C/C=O
Molecular Formula
C6H10O
Molecular Weight
98.15
Precautions
H226, H302, H311
References & Citations
[1]Konidari CN, et al. Determination of plasma, urine, and bovine serum albumin low-molecular-weight carbonyl levels by capillary gas chromatography with electron-capture and mass-selective detection.Anal Biochem. 2005 Mar 1;338 (1) :62-70.|[2]Gardner H W, et al. Hexanal, trans-2-hexenal, and trans-2-nonenal inhibit soybean, Glycine max, seed germination. Journal of Agricultural and Food Chemistry, 1990, 38 (6) : 1316-1320.|[3]Zhang J, et al. Antifungal activity of trans‐2‐hexenal against Penicillium cyclopium by a membrane damage mechanism. Journal of Food Biochemistry, 2017, 41 (2) : e12289.|[4]Hatanaka A, et al. Formation of cis-3-hexenal, trans-2-hexenal and cis-3-hexenol in macerated Thea sinensis leaves. Phytochemistry, 1973, 12 (10) : 2341-2346.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Natural Products
Clinical Information
No Development Reported